The Egyptian Drug Authority (EDA) Chairman Ali El Ghamrawy took part in the 8th Pharma Forum and the 9th Annual Arab International Pharmacy Conference, held under the theme “Intelligent and Integrated One Health Approach” under the EDA and the Egyptian Authority for Unified Procurement (UPA), according to a statement by the Egyptian Cabinet.

The forum spotlighted Egypt’s national effort to localize pharmaceutical manufacturing, attract advanced production technologies, introduce new regulatory standards, and provide incentives for both local and international firms.

El Ghamrawy said localization is a top national priority, noting that Egypt is the first African country—and one of only 18 globally—to achieve WHO’s Level 3 maturity in vaccine and drug regulation. With over 170 pharmaceutical factories, 2,370 production lines, and 91.3 per cent self-sufficiency in medicines, Egypt is steadily strengthening pharmaceutical security.

The EDA supports technology transfer partnerships that have already localized 129 medicines, saving $633.7 million in imports. It now aims to localize 400 active ingredients worth $1.57 billion, alongside new investment incentives to attract more partners and boost innovation.

El Ghamrawy underscored the key role of researchers in bridging science and industry, saying Egypt has the talent and infrastructure to emulate leading pharmaceutical nations like the US, China, and South Korea.

Amwal El Ghad